Intech Investment Management LLC Takes Position in Everus (NYSE:ECG)

Intech Investment Management LLC bought a new stake in shares of Everus (NYSE:ECGFree Report) in the fourth quarter, Holdings Channel.com reports. The fund bought 83,430 shares of the company’s stock, valued at approximately $5,486,000.

A number of other large investors have also recently made changes to their positions in the stock. Advisors Asset Management Inc. purchased a new stake in shares of Everus during the fourth quarter valued at $3,893,000. Thrivent Financial for Lutherans purchased a new stake in shares of Everus during the fourth quarter valued at $2,590,000. Corient Private Wealth LLC purchased a new stake in shares of Everus during the fourth quarter valued at $239,000. Natixis Advisors LLC purchased a new stake in shares of Everus during the fourth quarter valued at $935,000. Finally, Commonwealth Equity Services LLC purchased a new stake in Everus in the fourth quarter worth about $2,129,000.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on ECG. Oppenheimer upped their price objective on shares of Everus from $70.00 to $80.00 and gave the stock an “outperform” rating in a research note on Tuesday, January 7th. Stifel Nicolaus lowered their price objective on shares of Everus from $85.00 to $67.00 and set a “buy” rating for the company in a research note on Thursday, February 13th. Finally, Wolfe Research began coverage on shares of Everus in a research note on Tuesday, December 3rd. They issued a “peer perform” rating for the company.

Read Our Latest Stock Analysis on ECG

Everus Price Performance

ECG stock opened at $37.74 on Wednesday. Everus has a one year low of $36.96 and a one year high of $77.93. The company has a quick ratio of 1.50, a current ratio of 1.58 and a debt-to-equity ratio of 0.47. The firm’s 50-day moving average price is $55.95.

Everus (NYSE:ECGGet Free Report) last released its quarterly earnings results on Tuesday, February 11th. The company reported $0.67 earnings per share for the quarter, missing analysts’ consensus estimates of $0.73 by ($0.06). Equities research analysts expect that Everus will post 2.49 earnings per share for the current year.

Insider Activity

In other news, Director Rocca Michael Della purchased 1,050 shares of the stock in a transaction dated Tuesday, February 18th. The shares were acquired at an average cost of $47.56 per share, for a total transaction of $49,938.00. Following the acquisition, the director now owns 2,027 shares of the company’s stock, valued at approximately $96,404.12. This represents a 107.47 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Edward A. Ryan purchased 1,400 shares of the stock in a transaction dated Tuesday, February 25th. The stock was purchased at an average price of $38.02 per share, for a total transaction of $53,228.00. Following the completion of the acquisition, the director now directly owns 14,928 shares in the company, valued at approximately $567,562.56. This represents a 10.35 % increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders have bought 3,750 shares of company stock worth $153,853.

About Everus

(Free Report)

Everus Construction Group is providing a full spectrum of construction services through its electrical and mechanical and transmission and distribution specialty contracting services principally in United States. Its specialty contracting services are provided to utility, transportation, commercial, industrial, institutional, renewable and other customers.

See Also

Want to see what other hedge funds are holding ECG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Everus (NYSE:ECGFree Report).

Institutional Ownership by Quarter for Everus (NYSE:ECG)

Receive News & Ratings for Everus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Everus and related companies with MarketBeat.com's FREE daily email newsletter.